This is the World's Most Expensive Drugs |
Medication is necessary for the patient to cure the disease. Unfortunately, some types of drug prices are still sky high. Even the most expensive drugs in the world priced at more than Rp 15 billion.
Glybera, which was developed by a private Dutch company uniQure, is the first gene therapy drug in the world is estimated to worth about U.S. $ 1.6 million or approximately USD 15.4 billion. Not surprisingly, this drug was crowned as the world's most expensive drugs.
Glybera is the first gene therapy approved in the independent healthcare market.
"This therapy will have a" dramatic impact "on patients," said Professor John Kastelein, of the University of Amsterdam, as dilansirWorldrecordacademy, Friday (25/01/2013).
By Joern Aldag, chief executive of uniQure based in Amsterdam, the drug is sold at a high price because of gene therapy to restore the natural function of the body and not just the short term fix.
Treatment is done by using a virus to fight LPLD (lipoprotein lipase deficiency), which can cause acute inflammation of the pancreas.
LPLD affects about one in a million people, they do not have to make an important gene that breaks down fat particles in the blood. This means that fat builds up in the blood causing abdominal pain and inflammation of the pancreas (pancreatitis) which is life-threatening.
This drug therapy uses a virus to infect muscle cells by copying the work of the gene. In addition to medications, other ways to manage this disease has a very low fat diet.
Glybera is the first gene therapy approved in the independent healthcare market.
"This therapy will have a" dramatic impact "on patients," said Professor John Kastelein, of the University of Amsterdam, as dilansirWorldrecordacademy, Friday (25/01/2013).
By Joern Aldag, chief executive of uniQure based in Amsterdam, the drug is sold at a high price because of gene therapy to restore the natural function of the body and not just the short term fix.
Treatment is done by using a virus to fight LPLD (lipoprotein lipase deficiency), which can cause acute inflammation of the pancreas.
LPLD affects about one in a million people, they do not have to make an important gene that breaks down fat particles in the blood. This means that fat builds up in the blood causing abdominal pain and inflammation of the pancreas (pancreatitis) which is life-threatening.
This drug therapy uses a virus to infect muscle cells by copying the work of the gene. In addition to medications, other ways to manage this disease has a very low fat diet.
